• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型三核铂配合物对顺铂敏感和顺铂耐药的人卵巢癌细胞系的影响:干扰细胞周期进程并诱导细胞凋亡。

Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis.

作者信息

Orlandi L, Colella G, Bearzatto A, Abolafio G, Manzotti C, Daidone M G, Zaffaroni N

机构信息

Dipartimento di Oncologia Sperimentale, Unita' Operativa # 10, Istituto Nazionale per lo Studio e la Cura dei Tumori, 20133, Milan, Italy.

出版信息

Eur J Cancer. 2001 Mar;37(5):649-59. doi: 10.1016/s0959-8049(00)00445-7.

DOI:10.1016/s0959-8049(00)00445-7
PMID:11290441
Abstract

We evaluated the effects of the trinuclear platinum complex, BBR 3464, in a human ovarian carcinoma cell line (OAW42) and in its cisplatin (CDDP)-resistant counterpart (OAW42MER). A 14-fold increased sensitivity to a 1-h BBR 3464 exposure was found in OAW42MER cells compared with their parental cell line. Flow cytometric experiments showed that BBR 3464 was able to induce a persistent block of OAW42 and OAW42MER cells in the G2M phase, whereas CDDP caused an initial accumulation of cells in the S phase followed by an increase in the G2M cell fraction in both cell lines. Exposure to equitoxic (IC(50)) drug concentrations induced programmed cell death in both cell lines. However, the percentage of cells with an apoptotic nuclear morphology was slightly higher after CDDP than BBR 3464 treatment in OAW42 cells, whereas the opposite pattern was observed in OAW42MER cells. Degradation of the nuclear lamin B was detected in OAW42 cells after exposure to each drug. Conversely, in OAW42MER cells lamin B cleavage was only appreciable after BBR 3464 exposure. In OAW42 cells, CDDP and BBR 3464 did not appreciably affect the mitochondrial membrane potential (Deltapsi(mt)), whereas in the OAW42MER cell line a marked Deltapsi(mt) reduction was observed after exposure to BBR 3464, but not to CDDP. The results of the study would suggest that the sensitivity to BBR 3464 observed in the CDDP-resistant OAW42MER cell line might be attributable to the ability of the trinuclear platinum complex to modify DNA in a way which is different from that of CDDP and, as a consequence, to induce different cellular responses to DNA damage such as the triggering of specific apoptotic pathways.

摘要

我们评估了三核铂配合物BBR 3464对人卵巢癌细胞系(OAW42)及其顺铂(CDDP)耐药对应细胞系(OAW42MER)的作用。与亲代细胞系相比,发现OAW42MER细胞对1小时BBR 3464暴露的敏感性增加了14倍。流式细胞术实验表明,BBR 3464能够使OAW42和OAW42MER细胞在G2M期持续阻滞,而CDDP导致细胞在S期初始积累,随后两个细胞系中G2M期细胞比例增加。暴露于等效毒性(IC(50))药物浓度会诱导两个细胞系发生程序性细胞死亡。然而,在OAW42细胞中,CDDP处理后具有凋亡核形态的细胞百分比略高于BBR 3464处理后,而在OAW42MER细胞中观察到相反的模式。在暴露于每种药物后,在OAW42细胞中检测到核纤层蛋白B的降解。相反,在OAW42MER细胞中,仅在暴露于BBR 3464后核纤层蛋白B的切割才明显。在OAW42细胞中,CDDP和BBR 3464对线粒体膜电位(Deltapsi(mt))没有明显影响,而在OAW42MER细胞系中,暴露于BBR 3464后观察到明显的Deltapsi(mt)降低,但暴露于CDDP后未观察到。该研究结果表明,在CDDP耐药的OAW42MER细胞系中观察到的对BBR 3464的敏感性可能归因于三核铂配合物以不同于CDDP的方式修饰DNA的能力,因此,诱导对DNA损伤的不同细胞反应,如触发特定的凋亡途径。

相似文献

1
Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis.一种新型三核铂配合物对顺铂敏感和顺铂耐药的人卵巢癌细胞系的影响:干扰细胞周期进程并诱导细胞凋亡。
Eur J Cancer. 2001 Mar;37(5):649-59. doi: 10.1016/s0959-8049(00)00445-7.
2
Cell growth inhibition, G2M cell cycle arrest and apoptosis induced by the imidazoacridinone C1311 in human tumour cell lines.咪唑并吖啶酮C1311在人肿瘤细胞系中诱导的细胞生长抑制、G2M期细胞周期阻滞和细胞凋亡。
Eur J Cancer. 2001 Oct;37(15):1953-62. doi: 10.1016/s0959-8049(01)00227-1.
3
Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.口服铂类药物JM216在三种对顺铂敏感和耐药的人卵巢癌细胞系中对Pt/DNA损伤的基因特异性修复及凋亡诱导作用
Br J Cancer. 1999 Dec;81(8):1294-303. doi: 10.1038/sj.bjc.6694381.
4
Cytotoxicity, cellular uptake and DNA binding of the novel trinuclear platinun complex BBR 3464 in sensitive and cisplatin resistant murine leukemia cells.
Anticancer Res. 1998 Jul-Aug;18(4C):3113-7.
5
BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.BBR 3464:一种新型三铂配合物,其临床前抗肿瘤疗效概况与顺铂不同。
Clin Cancer Res. 2000 Jul;6(7):2626-34.
6
In vitro and in vivo antitumor activity of the novel trinuclear platinum complex BBR 3464 in neuroblastoma.新型三核铂配合物BBR 3464在神经母细胞瘤中的体外和体内抗肿瘤活性
Cancer Chemother Pharmacol. 2001 Jun;47(6):498-504. doi: 10.1007/s002800000264.
7
Modulation of melphalan and cisplatin cytotoxicity in human ovarian cancer cells resistant to alkylating drugs.对烷化剂耐药的人卵巢癌细胞中美法仑和顺铂细胞毒性的调节
Anticancer Drugs. 1997 Jun;8(5):509-16. doi: 10.1097/00001813-199706000-00014.
8
A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system.一种新型三核铂配合物在骨肉瘤细胞系统中克服顺铂耐药性。
Mol Pharmacol. 1999 Mar;55(3):528-34.
9
Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells.卵巢癌细胞对一种三核铂配合物耐药性的产生
Int J Cancer. 2003 Jul 10;105(5):617-24. doi: 10.1002/ijc.11140.
10
A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts.一种对顺铂耐药肿瘤有效的新型带电荷三核铂配合物:p53突变型人肿瘤异种移植瘤的超敏反应
Br J Cancer. 1999 Aug;80(12):1912-9. doi: 10.1038/sj.bjc.6690620.

引用本文的文献

1
Biological Evaluation of Dinuclear Platinum(II) Complexes with Aromatic -Heterocycles as Bridging Ligands.芳香杂环桥联双核铂(II)配合物的生物学评价。
Int J Mol Sci. 2024 Aug 5;25(15):8525. doi: 10.3390/ijms25158525.
2
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.下一代铂类药物:靶向铂(II)剂、纳米颗粒递送及铂(IV)前药
Chem Rev. 2016 Mar 9;116(5):3436-86. doi: 10.1021/acs.chemrev.5b00597. Epub 2016 Feb 11.
3
Increased toxicity of a trinuclear Pt-compound in a human squamous carcinoma cell line by polyamine depletion.
多胺耗竭增强三核铂配合物在人鳞癌细胞系中的毒性。
Cancer Cell Int. 2012 May 28;12(1):20. doi: 10.1186/1475-2867-12-20.
4
Trans-platinum(II) complexes with cyclohexylamine as expectator ligand induce necrosis in tumour cells by inhibiting DNA synthesis and RNA transcription.以环己胺作为旁观配体的反式铂(II)配合物通过抑制DNA合成和RNA转录诱导肿瘤细胞坏死。
Clin Transl Oncol. 2007 Aug;9(8):521-30. doi: 10.1007/s12094-007-0096-2.
5
Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.肿瘤抑制蛋白p53对新型抗肿瘤三核铂药物BBR3464和顺铂修饰的DNA的差异识别。
Nucleic Acids Res. 2004 Oct 14;32(18):5546-52. doi: 10.1093/nar/gkh896. Print 2004.